IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 14, 2023 08:00 ET | Imunon, Inc.
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins...
Recombinant DNA Technology Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand, and Forecast
September 04, 2023 07:28 ET | Fortune Business Insights
Pune, India, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The global recombinant DNA technology market is expected to grow during 2023 to 2030. The growth of the market is driven by the increasing demand for...
Vantage Market Research.png
Recombinant DNA Technology Market Economy Size Expected a Growth of USD 223.0 Billion by 2028, According to Vantage Market Research
September 08, 2022 09:41 ET | Vantage Market Research
WASHINGTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Recombinant DNA Technology Market finds that the increasing strategic collaborations among key...